Key Stats for AdaptHealth Stock
- Price change for AdaptHealth stock: 9%
- $AHCO Share Price as of Mar. 13: $11
- 52-Week High: $11
- $AHCO Stock Price Target: $13
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
AdaptHealth (AHCO) stock jumped 9% on Friday after a major shareholder made a significant bet on the company.
Richard M. Cashin Jr., listed as a 10% owner, purchased over two million shares across three days, spending roughly $19.9 million.
Share prices ranged from $9.55 to $9.95 per share.
Following the transactions, the reporting group now holds nearly 15.9 million shares.
Large insider purchases like this tend to catch the market’s attention.
When someone with deep knowledge of a business spends $20 million of their own money buying shares, it signals they see real value at current prices.
See analysts’ growth forecasts and price targets for AdaptHealth stock (It’s free) >>>
What the Market Is Telling Us About AdaptHealth Stock
AdaptHealth stock has been volatile. Today’s move fits that pattern, but the insider purchase gives it a different feel than most of those swings.
The stock is still recovering from a rough earnings report three weeks ago, when shares dropped 16.4% after Q4 results disappointed.
- Revenue of $846.3 million beat estimates, but the bottom line was ugly.
- The company posted a GAAP loss of $0.76 per share, well below the $0.35 profit analysts expected.
- Operating margins swung from positive 11.4% to negative 8.7% year-over-year.
- Adjusted EBITDA of $163.1 million also missed forecasts by more than 14%.
That said, the underlying business showed real progress.
Patient census hit all-time highs across sleep health, respiratory health, and at-home wellness.
The company paid down $250 million in debt during 2025 and generated $219 million in free cash flow. Both S&P and Moody’s upgraded AdaptHealth’s credit rating during the quarter.
The bigger story heading into 2026 is the company’s new capitated contract, which management called the largest service transition in the history of the home medical equipment industry.
Revenue from that contract is expected to ramp through the year, contributing 5% to 6% of total growth.
If execution stays on track, AdaptHealth stock could look very different by year-end.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does AdaptHealth Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
